These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 27895579)

  • 1. Pharmacodynamic Modeling of Cell Cycle Effects for Gemcitabine and Trabectedin Combinations in Pancreatic Cancer Cells.
    Miao X; Koch G; Ait-Oudhia S; Straubinger RM; Jusko WJ
    Front Pharmacol; 2016; 7():421. PubMed ID: 27895579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacodynamic modeling of combined chemotherapeutic effects predicts synergistic activity of gemcitabine and trabectedin in pancreatic cancer cells.
    Miao X; Koch G; Straubinger RM; Jusko WJ
    Cancer Chemother Pharmacol; 2016 Jan; 77(1):181-93. PubMed ID: 26604207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systems Pharmacodynamic Model of Combined Gemcitabine and Trabectedin in Pancreatic Cancer Cells. Part II: Cell Cycle, DNA Damage Response, and Apoptosis Pathways.
    Miao X; Koch G; Shen S; Wang X; Li J; Shen X; Qu J; Straubinger RM; Jusko WJ
    J Pharm Sci; 2024 Jan; 113(1):235-245. PubMed ID: 37918792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacodynamic modeling of cell cycle and apoptotic effects of gemcitabine on pancreatic adenocarcinoma cells.
    Hamed SS; Straubinger RM; Jusko WJ
    Cancer Chemother Pharmacol; 2013 Sep; 72(3):553-63. PubMed ID: 23835677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systems pharmacodynamic model of combined gemcitabine and trabectedin in pancreatic cancer cells. Part I.Çô Effects on signal transduction pathways related to tumor growth.
    Miao X; Shen S; Koch G; Wang X; Li J; Shen X; Qu J; Straubinger RM; Jusko WJ
    J Pharm Sci; 2024 Jan; 113(1):214-227. PubMed ID: 38498417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination effects of amino acid transporter LAT1 inhibitor nanvuranlat and cytotoxic anticancer drug gemcitabine on pancreatic and biliary tract cancer cells.
    Nishikubo K; Ohgaki R; Liu X; Okanishi H; Xu M; Endou H; Kanai Y
    Cancer Cell Int; 2023 Jun; 23(1):116. PubMed ID: 37322479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced G2/M Arrest, Caspase Related Apoptosis and Reduced E-Cadherin Dependent Intercellular Adhesion by Trabectedin in Prostate Cancer Stem Cells.
    Acikgoz E; Guven U; Duzagac F; Uslu R; Kara M; Soner BC; Oktem G
    PLoS One; 2015; 10(10):e0141090. PubMed ID: 26485709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell cycle effects of fatty acid derivatives of cytarabine, CP-4055, and of gemcitabine, CP-4126, as basis for the interaction with oxaliplatin and docetaxel.
    Adema AD; Laan AC; Myhren F; Fichtner I; Verheul HM; Sandvold ML; Peters GJ
    Int J Oncol; 2010 Jan; 36(1):285-94. PubMed ID: 19956857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antifibrotic Agent Pirfenidone Suppresses Proliferation of Human Pancreatic Cancer Cells by Inducing G0/G1 Cell Cycle Arrest.
    Usugi E; Ishii K; Hirokawa Y; Kanayama K; Matsuda C; Uchida K; Shiraishi T; Watanabe M
    Pharmacology; 2019; 103(5-6):250-256. PubMed ID: 30731453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comprehensive complex systems approach to the study and analysis of mammalian cell cycle control system in the presence of DNA damage stress.
    Abroudi A; Samarasinghe S; Kulasiri D
    J Theor Biol; 2017 Sep; 429():204-228. PubMed ID: 28647496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic Effect of Trabectedin and Olaparib Combination Regimen in Breast Cancer Cell Lines.
    Ávila-Arroyo S; Nuñez GS; García-Fernández LF; Galmarini CM
    J Breast Cancer; 2015 Dec; 18(4):329-38. PubMed ID: 26770239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trabectedin and Campthotecin Synergistically Eliminate Cancer Stem Cells in Cell-of-Origin Sarcoma Models.
    Martinez-Cruzado L; Tornin J; Rodriguez A; Santos L; Allonca E; Fernandez-Garcia MT; Astudillo A; Garcia-Pedrero JM; Rodriguez R
    Neoplasia; 2017 Jun; 19(6):460-470. PubMed ID: 28494349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Semimechanistic pharmacokinetic/pharmacodynamic model for hepatoprotective effect of dexamethasone on transient transaminitis after trabectedin (ET-743) treatment.
    Fetterly GJ; Owen JS; Stuyckens K; Passarell JA; Zannikos P; Soto-Matos A; Izquierdo MA; Perez-Ruixo JJ
    Cancer Chemother Pharmacol; 2008 Jun; 62(1):135-47. PubMed ID: 17922277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activity of trabectedin and the PARP inhibitor rucaparib in soft-tissue sarcomas.
    Laroche A; Chaire V; Le Loarer F; Algéo MP; Rey C; Tran K; Lucchesi C; Italiano A
    J Hematol Oncol; 2017 Apr; 10(1):84. PubMed ID: 28399901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PARP1 expression drives the synergistic antitumor activity of trabectedin and PARP1 inhibitors in sarcoma preclinical models.
    Pignochino Y; Capozzi F; D'Ambrosio L; Dell'Aglio C; Basiricò M; Canta M; Lorenzato A; Vignolo Lutati F; Aliberti S; Palesandro E; Boccone P; Galizia D; Miano S; Chiabotto G; Napione L; Gammaitoni L; Sangiolo D; Benassi MS; Pasini B; Chiorino G; Aglietta M; Grignani G
    Mol Cancer; 2017 Apr; 16(1):86. PubMed ID: 28454547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell-cycle progression and response of germ cell tumors to cisplatin in vitro.
    Mueller S; Schittenhelm M; Honecker F; Malenke E; Lauber K; Wesselborg S; Hartmann JT; Bokemeyer C; Mayer F
    Int J Oncol; 2006 Aug; 29(2):471-9. PubMed ID: 16820891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperthermia adds to trabectedin effectiveness and thermal enhancement is associated with BRCA2 degradation and impairment of DNA homologous recombination repair.
    Harnicek D; Kampmann E; Lauber K; Hennel R; Cardoso Martins AS; Guo Y; Belka C; Mörtl S; Gallmeier E; Kanaar R; Mansmann U; Hucl T; Lindner LH; Hiddemann W; Issels RD
    Int J Cancer; 2016 Jul; 139(2):467-79. PubMed ID: 26933761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of 5-fluouracil combined with sulfasalazine on human pancreatic carcinoma cell line BxPC-3 proliferation and apoptosis in vitro.
    Huang Z; Guo KJ; Guo RX; He SG
    Hepatobiliary Pancreat Dis Int; 2007 Jun; 6(3):312-20. PubMed ID: 17548258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cervical cancer benefits from trabectedin combination with the β-blocker propranolol:
    Di Fonte R; Strippoli S; Garofoli M; Cormio G; Serratì S; Loizzi V; Fasano R; Arezzo F; Volpicella M; Derakhshani A; Guida M; Porcelli L; Azzariti A
    Front Cell Dev Biol; 2023; 11():1178316. PubMed ID: 37384250
    [No Abstract]   [Full Text] [Related]  

  • 20. Apoptosis during HL-60 cell differentiation is closely related to a G0/G1 cell cycle arrest.
    Terui Y; Furukawa Y; Kikuchi J; Saito M
    J Cell Physiol; 1995 Jul; 164(1):74-84. PubMed ID: 7790399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.